Investors

Corporate News

Annual Report and Accounts
Notice of Annual General Meeting

06 June 2017

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that in accordance with AIM Rule 20, electronic copies of its Annual Report and Accounts for the year ended 31 January 2017 together with the Notice of Annual General Meeting and Form of Proxy are available from the Company's investor relations website at http://ir.quantumpharmagroup.com. Hard copies of the 2017 Annual Report and Accounts, Notice of Annual General Meeting and Form of Proxy were posted to shareholders yesterday.

The Company's Annual General Meeting will be held at 1:00 p.m. on Thursday, 6 July 2017 at the offices of Muckle LLP, Time Central, 32 Gallowgate, Newcastle upon Tyne, NE1 4BF.

Notice of AGM 2017 to be held on 6 July 2017

Form of Proxy for AGM to be held on 6 July 2017

2017 Annual Report

 

For further information:

Quantum Pharma Plc  
Chris Rigg, Chief Executive Officer Tel: +44 (0) 1207 279 404
Gerard Murray, Chief Financial Officer www.quantumpharmagroup.com
ir@quantumpharma.co.uk  
   
N+1 Singer
(Nominated Advisor & Broker)
 
Sandy Fraser / Nick Owen / James White Tel: +44 (0) 20 7496 3000
   
Media enquiries:  
Buchanan  
Henry Harrison-Topham / Sophie Cowles Tel: +44 (0) 20 7466 5000
quantumpharma@buchanan.uk.com www.buchanan.uk.com

 

Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital and homecare markets. Quantum Pharma Plc operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.

For further information, please visit www.quantumpharmagroup.com.

 

back to top

back to Corporate News

 

 
Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
Biodose Intelligent Medication Management